HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Schneeweiss Selected Research

Breast Neoplasms (Breast Cancer)

3/2022MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.
2/2022Update Breast Cancer 2021 Part 4 - Prevention and Early Stages.
1/2022Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial.
1/2022Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer.
1/2022Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.
1/2022Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial.
1/2022Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls.
1/2022Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial.
1/2022Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.
1/2022Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Schneeweiss Research Topics

Disease

263Breast Neoplasms (Breast Cancer)
03/2022 - 01/2002
145Neoplasms (Cancer)
09/2022 - 01/2002
32Triple Negative Breast Neoplasms
01/2022 - 10/2013
27Neoplasm Metastasis (Metastasis)
10/2021 - 03/2004
17Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 12/2007
14Pathologic Complete Response
05/2021 - 12/2004
14Disease Progression
07/2020 - 04/2004
13Circulating Neoplastic Cells
07/2020 - 08/2011
9Carcinoma (Carcinomatosis)
01/2020 - 04/2010
9Fatigue
01/2020 - 10/2005
7Neutropenia
01/2020 - 06/2009
6Ovarian Epithelial Carcinoma
01/2016 - 12/2007
5Cardiotoxicity
12/2020 - 04/2004
5Nausea
01/2020 - 02/2008
5Vomiting
01/2020 - 04/2007
5Diarrhea
10/2018 - 12/2004
4Brain Neoplasms (Brain Tumor)
01/2022 - 12/2015
4Residual Neoplasm
01/2019 - 11/2015
3Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 01/2020
3Thrombocytopenia (Thrombopenia)
09/2015 - 06/2009
3Febrile Neutropenia
05/2013 - 12/2004
2COVID-19
09/2022 - 01/2022
2Cytokine Release Syndrome
09/2022 - 01/2022
2Pain (Aches)
08/2021 - 12/2019

Drug/Important Bio-Agent (IBA)

51Hormones (Hormone)IBA
01/2022 - 01/2002
30Estrogen ReceptorsIBA
03/2022 - 02/2004
26taxaneIBA
01/2022 - 01/2005
24Biomarkers (Surrogate Marker)IBA
03/2022 - 11/2012
24human ERBB2 proteinIBA
01/2021 - 07/2010
21Phenobarbital (Luminal)FDA Link
01/2022 - 06/2013
21AnthracyclinesIBA
01/2022 - 02/2004
20Trastuzumab (Herceptin)FDA Link
01/2020 - 03/2004
16Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 06/2009
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 04/2007
15Epirubicin (Ellence)FDA LinkGeneric
01/2022 - 12/2004
15Docetaxel (Taxotere)FDA Link
01/2020 - 12/2004
14pertuzumabIBA
11/2020 - 03/2013
13Progesterone Receptors (Progesterone Receptor)IBA
03/2022 - 02/2004
13MicroRNAs (MicroRNA)IBA
01/2022 - 06/2011
13DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
13Biological ProductsIBA
01/2020 - 07/2002
12130-nm albumin-bound paclitaxelIBA
01/2022 - 08/2013
12Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2002
10Carboplatin (JM8)FDA LinkGeneric
01/2022 - 04/2009
10Pharmaceutical PreparationsIBA
02/2021 - 01/2005
10GemcitabineFDA Link
10/2020 - 12/2004
9ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2005
9PlatinumIBA
08/2016 - 12/2007
8Immune Checkpoint InhibitorsIBA
01/2022 - 03/2019
8Bevacizumab (Avastin)FDA Link
12/2021 - 07/2010
8AntigensIBA
12/2017 - 01/2006
7atezolizumabIBA
11/2021 - 11/2018
7AntibodiesIBA
01/2020 - 11/2003
6liposomal doxorubicin (Doxil)FDA Link
01/2022 - 02/2014
6Zoledronic Acid (Zometa)FDA Link
08/2021 - 05/2010
5Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2022 - 03/2018
5Tumor Biomarkers (Tumor Markers)IBA
03/2020 - 03/2010
5TamoxifenFDA LinkGeneric
01/2020 - 01/2010
4TabletsIBA
01/2022 - 01/2017
4CytokinesIBA
01/2022 - 01/2007
4Diphosphonates (Bisphosphonates)IBA
08/2021 - 10/2013
4Immunoconjugates (Immunoconjugate)IBA
05/2021 - 01/2019
4Messenger RNA (mRNA)IBA
01/2021 - 08/2017
4RNA (Ribonucleic Acid)IBA
01/2021 - 04/2006
4Ado-Trastuzumab EmtansineIBA
10/2020 - 01/2019
4Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 12/2004
3B7-H1 AntigenIBA
11/2021 - 11/2018
3Estrogens (Estrogen)FDA Link
08/2020 - 06/2009
3Indicators and Reagents (Reagents)IBA
07/2020 - 06/2013
3Transcription Factors (Transcription Factor)IBA
01/2020 - 04/2013
3Monoclonal AntibodiesIBA
01/2020 - 04/2004
3EverolimusFDA Link
02/2019 - 02/2016
3exemestane (Aromasin)FDA Link
02/2019 - 01/2018
3Cell-Free Nucleic AcidsIBA
05/2018 - 07/2014
33' Untranslated Regions (3' UTR)IBA
11/2016 - 01/2014
3EnzymesIBA
11/2015 - 04/2007
3Neoplasm Antigens (Tumor Antigens)IBA
06/2015 - 03/2010
3ParaffinIBA
10/2014 - 01/2002
3Formaldehyde (Formol)FDA Link
10/2014 - 01/2002
3Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2008 - 12/2004
2Cyclin-Dependent Kinase 4IBA
12/2021 - 05/2021

Therapy/Procedure

117Therapeutics
01/2022 - 03/2004
86Drug Therapy (Chemotherapy)
03/2022 - 01/2002
48Neoadjuvant Therapy
02/2022 - 12/2004
21Adjuvant Chemotherapy
08/2021 - 07/2007
15Radiotherapy
01/2022 - 11/2006
11Immunotherapy
09/2022 - 06/2015
6Segmental Mastectomy (Lumpectomy)
01/2019 - 12/2004
6Palliative Care (Palliative Therapy)
01/2017 - 04/2007
5Salvage Therapy
01/2016 - 09/2007
4Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 01/2008
3Operative Surgical Procedures
10/2021 - 10/2012
3Mastectomy (Mammectomy)
11/2019 - 11/2013
3Cytoreduction Surgical Procedures
10/2019 - 01/2011
3Lymph Node Excision (Lymph Node Dissection)
01/2019 - 05/2013
3Aftercare (After-Treatment)
11/2018 - 12/2015
3Precision Medicine
11/2018 - 06/2013
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2011 - 12/2007
2Duration of Therapy
08/2021 - 10/2011
2Resistance Training
01/2021 - 01/2013